Updated COVID-19 boosters will be available for all Ontarians later this month. Are they still effective?
Health Canada has approved new COVID-19 vaccines targeting the KP.2 variant. But with XEC on the rise, are they still effective?
ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX's Comirnaty
Arcturus stock gains as the company reports that its sa-mRNA COVID-19 vaccine, ARCT-154, shows superior efficacy compared ...
Arcturus Therapeutics: A Strong Buy on Superior Vaccine Efficacy and Market Potential
Wells Fargo analyst Yanan Zhu has assigned their bullish stance on ARCT stock, giving a Buy rating on September 19. Yanan Zhu has given his ...
psychiatryadvisor.com3d
FDA OKs KP.2-Adapted COVID-19 Vaccines for 2024-2025 Season
The updated formulation pertains to both approved (Comirnaty and Spikevax) and authorized (Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine) mRNA vaccines. The 2024-2025 mRNA COVID-19 ...
biopharma-reporter3d
Self-amplifying mRNA COVID-19 vaccine shows superiority over conventional mRNA vaccine
A head-to-head study has revealed that CSL and Arcturus Therapeutic’s self-amplifying mRNA vaccine can maintain a stronger ...
CSL, Arcturus's Sa-mRNA COVID-19 Vaccine Shows Positive Immune Response; Stock Up
CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...
Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses
CSL Limited (OTC:CSLLY) and Arcturus Therapeutics (NASDAQ:ARCT) announced the results of a Phase 3 head-to-head study of ARCT ...
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
Doctors advise adding COVID-19 to your list of vaccines this cold and flu season
Since the virus that causes COVID-19 mutates rapidly, new variants regularly emerge and vaccines need to be adjusted ...